These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27255290)

  • 1. Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione.
    Morrison R; Al-Rawi JM
    J Enzyme Inhib Med Chem; 2016; 31(sup2):86-95. PubMed ID: 27255290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines.
    Ihmaid S; Al-Rawi J; Bradley C; Angove MJ; Robertson MN; Clark RL
    Bioorg Med Chem; 2011 Jul; 19(13):3983-94. PubMed ID: 21664823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
    Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
    Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of linear and angular aryl-morpholino-naphth-oxazines, their DNA-PK, PI3K, PDE3A and antiplatelet activity.
    Morrison R; Zheng Z; Jennings IG; Thompson PE; Al-Rawi JMA
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5534-5538. PubMed ID: 27765510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 8-aryl-2-morpholino-7-O-substituted benzo[e][1,3]oxazin-4-ones against DNA-PK, PI3K, PDE3A enzymes and platelet aggregation.
    Saifuzzaman M; Morrison R; Zheng Z; Orive S; Hamilton J; Thompson PE; Al-Rawi JMA
    Bioorg Med Chem; 2017 Oct; 25(20):5531-5536. PubMed ID: 28838830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach.
    Hardcastle IR; Cockcroft X; Curtin NJ; El-Murr MD; Leahy JJ; Stockley M; Golding BT; Rigoreau L; Richardson C; Smith GC; Griffin RJ
    J Med Chem; 2005 Dec; 48(24):7829-46. PubMed ID: 16302822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines.
    Morrison R; Al-Rawi JM; Jennings IG; Thompson PE; Angove MJ
    Eur J Med Chem; 2016 Mar; 110():326-39. PubMed ID: 26854431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-dependent protein kinase (DNA-PK) inhibitors: structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain.
    Clapham KM; Bardos J; Finlay MR; Golding BT; Griffen EJ; Griffin RJ; Hardcastle IR; Menear KA; Ting A; Turner P; Young GL; Cano C
    Bioorg Med Chem Lett; 2011 Feb; 21(3):966-70. PubMed ID: 21216595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives.
    Clapham KM; Rennison T; Jones G; Craven F; Bardos J; Golding BT; Griffin RJ; Haggerty K; Hardcastle IR; Thommes P; Ting A; Cano C
    Org Biomol Chem; 2012 Sep; 10(33):6747-57. PubMed ID: 22814419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.
    Peng W; Tu ZC; Long ZJ; Liu Q; Lu G
    Eur J Med Chem; 2016 Jan; 108():644-654. PubMed ID: 26731167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of a new series of 3-[3-(substituted phenyl)-1-phenyl-1H-pyrazol-5-yl]-2H-chromen-2-one derivatives.
    Aragade P; Narayanan RV; Maddi V; Patil P; Shinde P; Agrawal M
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):849-53. PubMed ID: 21988189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity.
    Cano C; Saravanan K; Bailey C; Bardos J; Curtin NJ; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Menear KA; Newell DR; Richardson CJ; Shea K; Smith GC; Thommes P; Ting A; Griffin RJ
    J Med Chem; 2013 Aug; 56(16):6386-401. PubMed ID: 23855836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
    Hollick JJ; Rigoreau LJ; Cano-Soumillac C; Cockcroft X; Curtin NJ; Frigerio M; Golding BT; Guiard S; Hardcastle IR; Hickson I; Hummersone MG; Menear KA; Martin NM; Matthews I; Newell DR; Ord R; Richardson CJ; Smith GC; Griffin RJ
    J Med Chem; 2007 Apr; 50(8):1958-72. PubMed ID: 17371003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-pot catalyst free synthesis of novel kojic acid tagged 2-aryl/alkyl substituted-4H-chromenes and evaluation of their antimicrobial and anti-biofilm activities.
    Bingi C; Emmadi NR; Chennapuram M; Poornachandra Y; Kumar CG; Nanubolu JB; Atmakur K
    Bioorg Med Chem Lett; 2015 May; 25(9):1915-9. PubMed ID: 25838145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of substituted flavones, 4-thioflavones and 4-iminoflavones.
    Ullah Mughal E; Ayaz M; Hussain Z; Hasan A; Sadiq A; Riaz M; Malik A; Hussain S; Choudhary MI
    Bioorg Med Chem; 2006 Jul; 14(14):4704-11. PubMed ID: 16603364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-peptide-based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies.
    Jaiswal PK; Sharma V; Kumar S; Mathur M; Swami AK; Yadav DK; Chaudhary S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700349. PubMed ID: 29522645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.
    Dong FD; Liu DD; Deng CL; Qin XC; Chen K; Wang J; Song HR; Ding HW
    Bioorg Med Chem; 2018 Aug; 26(14):3982-3991. PubMed ID: 29937355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents.
    Giordanetto F; Barlaam B; Berglund S; Edman K; Karlsson O; Lindberg J; Nylander S; Inghardt T
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3936-43. PubMed ID: 25042253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction.
    Hossein nia R; Mamaghani M; Tabatabaeian K; Shirini F; Rassa M
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5956-60. PubMed ID: 22892120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibitors of phosphatidylinositol 3 (PI3) kinase that have antiproliferative activity only when delivered as prodrug forms.
    O'Brien NJ; Amran S; Medan J; Cleary B; Deady LW; Jennings IG; Thompson PE; Abbott BM
    ChemMedChem; 2013 Jun; 8(6):914-8. PubMed ID: 23568455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.